HSBC Asia Pacific Ex Japan Screen Equity UCITS GBP ETF (HSXD)

Well, most of have reached the 3.5 year point from our last shot, so we can be confident that the vaccine has cleared. What’s the point of this article?

For a minute there i thought about lucky Gilmore..........

😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹

LOLOLOLOL!

Buy, buy, buy... Hold, hold, hold... Profit, profit, profit. BULLISH!!!

Nonsense, lol. Craig Marshak holds the Wertheim trademark name and sits on your company's board as a private director of that company, per se, lmao!

500 million more shares added today

Charles Schwab shows $0.10. The chart on E*Trade shows $0.10. I am convinced $0.10 is the true price. I had an order to Sell at $0.10. At this point, I will not sell for less than $0.10. BULLISH!!!

I think GetRch$lwly laid out a reasonable “everything goes perfectly” scenario, but I still think it’s probably too optimistic.

NAMSA absolutely improves the odds of getting the IDE right the first time, but it doesn’t eliminate FDA review timelines or potential questions. They still

🤑SNTX🤑 You All Ready To See A Million + In Your Accounts $🤑$🤑$🤑$🤑$🤑$🤑$🤑Elon Be Liking Mr Leal !

$OSRH what is there not to like 💎 
- $815 million funding for advancing their drug VAXIM while looking for a big pharmaceutical partner during that process.
- $15 million in funding starting in October at $10 a share
- a NDA with a 8 billion in sales company to investiga

$OSRH what is there not to like 💎 
- $815 million funding for advancing their drug VAXIM while looking for a big pharmaceutical partner during that process.
- $15 million in funding starting in October at $10 a share
- a NDA with a 8 billion in sales company to investiga

I know most do not follow charts and think they are useless for low cap bio. They have been right for the last five years. In order for that to change I believe we need to see volume of 10 million shares on big news. Here is the chart.
https://schrts.co/mHVrctPW

• “…recognizing the impact this medicine could potentially have.”
This could be true of every single treatment that is up for approval, as a new treatment not yet available prior to approval,

https://x.com/GuidoPerei/status/2075395630298804549?s=20

One new comment on today's The Luminary Live program from Rodolfo Taylor:

https://www.linkedin.com/in/robertblum/recent-activity/comments/

Rodolfo Taylor
Automotive Professional Consultant. Specializing in Next-Gen Mobility, Advancing the Transition from Copper t

https://x.com/GuidoPerei/status/2075395630298804549?s=20

Australian Firms Shift Cybersecurity Focus to ResilienceJuly 9, 2026 9:43 PM
Business Wire Organizations seek partners with local capabilities, including AI risk management and regulatory readiness, ISG Provider Lens® report says Enterprises

barnstormer, are you okay? Marnix Bosch is one person. Not being facetious, do you feel okay?

Definitely getting the feeling these guys took the summer off. Hopefully not the case.

2...$MWWC...no fraud. Mr. Blagman has a lifelong history of major accomplishments in the entertainment business. Anyone who investigates can tell that
.

$TWOH

Yes sir. Any decent volume and this will move fast and hard

0 for 4 attempts at posting a video...


https://external-content.duckduckgo.com/iu/?u=https%3A%2F%2Fi.ytimg.com%2Fvi%2FeOifa1WrOnQ%2Fmaxresdefault.jpg&f=1&nofb=1&ipt=85c60879bc24c479fc89a70fbed01dccec5f94874b06bc84fa01896325fcdb7e

INDUSTRY ENGAGEMEMT
BKTH is currently engaged with multiple global leaders evaluating PFAS-free transitions across automotive, architectural, solar, packaging, and industrial verticals as regulatory timelines accelerate.
SOON WE WILL HAVE SIGNED CONTRACTS
GO $BKTH